As a way to better support and manage multiple research projects, The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 27 cancer centres, has implemented a new web-based software programme into their Oncology Research Programme (ORP).
Known as iEnvision, the programme was developed by scientific communications and technology solutions company Envision Pharma Group to support medical affairs-related programmes of activity.
In this particular case, iEnvision will support investigator-led studies for the NCCN’s ORP, which supports research through collaborations with pharmaceutical companies by drawing on the expertise of investigators from cancer centres.
Susan Most, director of clinical operations for the NCCN ORP, said: “Switching to Envision’s web-based system has allowed the ORP to streamline our process for managing proposals and investigator-initiated clinical trials, making it easier to manage research that will improve patients’ quality-of-life and reduce cancer-related deaths.
“Envision worked with us to adapt their platform to meet the specific needs of our applicants, reviewers and institutions and we’re now able to accept and review proposals in a more efficient, user-friendly manner.”
The NCCN plans to use the system to process around 50 proposal submissions and manage 70 active studies annually.
Additionally, the system will enable the management of studies in an ‘efficient’ manner, facilitating grant applicants, NCCN staff and peer reviewers and the ability to upgrade and make changes to the system each year.
Kelli Walker, director of platform strategy for Envision, said: “We are pleased to have been able to provide the adaptation of our industry standard study management iEnvision module for NCCN, supporting their industry-wide coordination of important, indepdent oncology research.”